Plain-English translation of NCT06682689 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcutaneous vagus nerve stimulation (tVNS)—a gentle, non-invasive treatment that uses a small wearable device to send mild electrical signals through the skin to a nerve in your neck. Researchers want to see whether this treatment can help prevent or reduce depression, anxiety, and mood problems that some women experience after giving birth. The study will compare different intensity levels of stimulation and track changes in mood, sleep, stress hormones, and overall mental health over 12 weeks.
After childbirth, many women struggle with postpartum depression, anxiety, and mood changes—sometimes called 'postpartum blues.' Current treatments don't work for everyone, and some women prefer non-medication options, especially while pregnant or breastfeeding. This trial explores whether stimulating a specific nerve in the neck might be a safe, effective way to prevent or reduce these mental health challenges before they become severe.
You likely qualify if…
You likely don't qualify if…
You would wear a small stimulation device on your neck for 12 weeks total—either at high intensity, low intensity, or not at all, depending on which group you're assigned to. Halfway through, some participants will switch to a different intensity level. Throughout the study, you'll answer quick mood check-ins on your phone, wear a smartwatch to track sleep and heart rate, complete mental health questionnaires at several visits, and provide a hair sample for stress hormone testing. Your partner may also be invited to complete questionnaires about their own wellbeing.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Germany